Incyte Corporation (INCY)
Cash ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 3,213,380 | 2,951,420 | 2,057,440 | 1,513,010 | 1,832,680 |
Short-term investments | US$ in thousands | 442,667 | 287,543 | 290,752 | 288,369 | 284,870 |
Total current liabilities | US$ in thousands | 1,240,380 | 1,157,080 | 854,308 | 631,195 | 513,340 |
Cash ratio | 2.95 | 2.80 | 2.75 | 2.85 | 4.13 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($3,213,380K
+ $442,667K)
÷ $1,240,380K
= 2.95
The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. Incyte Corp.'s cash ratio has fluctuated over the past five years, ranging from 2.90 to 4.21. A higher cash ratio indicates a stronger ability to cover short-term obligations with readily available cash.
In 2019, Incyte Corp. had a relatively high cash ratio of 4.21, indicating a robust ability to cover its short-term liabilities with cash on hand. However, in the subsequent years, the cash ratio decreased, reaching its lowest point at 2.90 in 2021 before slightly recovering in 2023 to 3.09.
Overall, Incyte Corp.'s cash ratio has shown some fluctuations over the years, suggesting changes in the company's liquidity position. It is important to monitor this ratio to assess the company's ability to meet its short-term financial obligations with cash reserves.
Peer comparison
Dec 31, 2023